Found: 28
Select item for more details and to access through your institution.
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries.
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 11, p. 1111, doi. 10.3899/jrheum.2024-0252
- By:
- Publication type:
- Article
Comparing DAPSA, DAPSA28, and DAS28‐CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 11, p. 1558, doi. 10.1002/acr.25396
- By:
- Publication type:
- Article
Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1659-z
- By:
- Publication type:
- Article
A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123582
- By:
- Publication type:
- Article
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 5, p. 1739, doi. 10.1007/s10067-020-05402-y
- By:
- Publication type:
- Article
Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 7, p. 1205, doi. 10.1002/acr.24560
- By:
- Publication type:
- Article
One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 5, p. 748, doi. 10.1002/acr.24523
- By:
- Publication type:
- Article
Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cut-Offs for Disease Activity States in Axial Spondylarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 7, p. 673, doi. 10.3899/jrheum.2023-1217
- By:
- Publication type:
- Article
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 8, p. 1009, doi. 10.3899/jrheum.220459
- By:
- Publication type:
- Article
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 3, p. 438, doi. 10.3899/jrheum.220317
- By:
- Publication type:
- Article
Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching.
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1882, doi. 10.1093/rheumatology/kead494
- By:
- Publication type:
- Article
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 751, doi. 10.1093/rheumatology/kead284
- By:
- Publication type:
- Article
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 647, doi. 10.1093/rheumatology/keac358
- By:
- Publication type:
- Article
Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4286, doi. 10.1093/rheumatology/keac081
- By:
- Publication type:
- Article
occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3647, doi. 10.1093/rheumatology/keab946
- By:
- Publication type:
- Article
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3799, doi. 10.1093/rheumatology/keab945
- By:
- Publication type:
- Article
Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3711, doi. 10.1093/rheumatology/keab894
- By:
- Publication type:
- Article
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3635, doi. 10.1093/rheumatology/keaa825
- By:
- Publication type:
- Article
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 9, p. 2455, doi. 10.1093/rheumatology/kez656
- By:
- Publication type:
- Article
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard care.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0266816
- By:
- Publication type:
- Article
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients.
- Published in:
- Rheumatology International, 2024, v. 44, n. 4, p. 675, doi. 10.1007/s00296-024-05536-1
- By:
- Publication type:
- Article
Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1171, doi. 10.1007/s40744-022-00464-7
- By:
- Publication type:
- Article
Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02294-w
- By:
- Publication type:
- Article
Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 4, p. 587, doi. 10.1002/art.42758
- By:
- Publication type:
- Article